---
figid: PMC9586725__ECAM2022-6177477.004
pmcid: PMC9586725
image_filename: ECAM2022-6177477.004.jpg
figure_link: /pmc/articles/PMC9586725/figure/fig4/
number: Figure 4
figure_title: ''
caption: 'Simvastatin inhibits the RAS/MAPK signaling pathway in Ishikawa cells. (a–d):
  Western blot to detect the effect of simvastatin with different concentrations on
  the expression of RAS/MAPK pathway-related proteins (RAS, p-MEK, MEK, p-ERK, and
  ERK) in Ishikawa cells (a), and quantitative analysis based on Image J (b–d), ∗P
  < 0.05 vs. control group; ##P < 0.01 vs. 5 μM group.'
article_title: Simvastatin Inhibits Endometrial Cancer Malignant Behaviors by Suppressing
  RAS/Mitogen-Activated Protein Kinase (MAPK) Pathway-Mediated Reactive Oxygen Species
  (ROS) and Ferroptosis.
citation: Dan Zhou, et al. Evid Based Complement Alternat Med. 2022;2022:6177477.
year: '2022'

doi: 10.1155/2022/6177477
journal_title: 'Evidence-based Complementary and Alternative Medicine : eCAM'
journal_nlm_ta: Evid Based Complement Alternat Med
publisher_name: Hindawi

keywords:
---
